Table:
begin	end	state
1	22	signal peptide
23	210	non-cytoplasmic
211	234	transmembrane
235	240	cytoplasmic
241	260	transmembrane
261	265	non-cytoplasmic
266	286	transmembrane
287	298	cytoplasmic
299	320	transmembrane
321	347	non-cytoplasmic
348	367	transmembrane
368	399	cytoplasmic
400	418	transmembrane
419	430	non-cytoplasmic
431	457	transmembrane
458	464	cytoplasmic
465	484	transmembrane
485	499	non-cytoplasmic

Input:
>AO353_13540
MSLYRLFLAIAFVLLPMVAHAGDAEDFVAANPVQQAKLLETWAAQPDPARIELINALQQG
QLSVDGEVRILRLNNRLRGLIDTALASHQLLAADTKVRLSAAQQLQKSAKPAQLKFLDQQ
LAGEKDPSVHAALSLALANLQLVDADPAVRLAAVRLLGETGDPLARTRLEGLLQPGVEAD
ATVHTAAETSLAQVKRKLLIGELLGQAFSGMSLGSILLLAALGLAITFGLLGVINMAHGE
MLMLGAYSTYVVQLLFQRFAPQAIEFYPLIALPVAFFVTAGIGMALERTVIRHLYGRPLE
TLLATWGISLMLIQLVRLLFGAQNVEVANPAWLSGGIQVLPNLVLPYNRIVIIAFALFVV
VLTWLLLNKTRLGLNVRAVTQNRNMAACCGVPTGRVDMLAFGLGSGIAGLGGVALSQVGN
VGPDLGQSYIIDSFLVVVLGGVGQLAGSVLAAFGLGIANKILEPQIGAVLGKILILALII
LFIQKRPQGLFALKGRVID

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server